藥物肽
Nafarelin Acetate
CAS No.:
86220-42-0/76932-56-4
Molecular formula:
C68H89N17O16
Molecular Weight:
1400.54
Amino acids sequence:
Pyr-His-Trp-Ser-Tyr-D-2-Nal-Leu-Arg-Pro-Gly-NH2
Application:
Nafarelin Acetate is the acetate salt form of nafarelin, a modified synthetic porcine luteinizing hormone (LH)-releasing hormone peptide analog, with gonadotropin-releasing hormone (GnRH) agonist activity. Upon nasal inhalation, nafarelin acetate binds to the GnRH receptor. This initially results in the release of the gonadotropins, follicle-stimulating hormone (FSH) and LH, from the pituitary gland; however, prolonged stimulation of the GnRH receptor desensitizes the receptor, which leads to decreased secretion of FSH and LH. In females, the inhibition of gonadotropin secretion causes hypogonadotropic hypogonadism leading to decreased production of estrogen and progesterone and anovulation. In males, the inhibition of LH secretion prevents the production and release of testosterone from Leydig cells in the testes and causes a significant decline in testosterone production that is near the levels seen following castration.
Notes: For research use only
聯(lián)系我們
微信公眾平臺(tái)
江蘇省南京市江北新區(qū)天圣路22號(hào)新材料科技園 New Material Technology Park, No. 22 Tiansheng Road, Jiangbei New District, Nanjing City, Jiangsu Province |
|
smalltao.cn | |
[email protected] | |
+86 25 86557173/ 58067593/ 83751537 |
南京萊昂生物科技有限公司
Leon (Nanjing) Biotechnology Co., Ltd.
南京萊昂生物科技有限公司 版權(quán)所有(C)2021 備案序號(hào):蘇ICP備18004987號(hào)-1